tenofovir disoproxil fumarate

AssetAlso called TDF, Tenofovir DF, Tenofovir DF (TDF), Tenofovir Disoproxil Fumarate (TDF)

Prodrug of tenofovir that inhibits hepatitis B viral polymerase, blocking viral DNA synthesis.

Stage
Approved
Modality
Small molecule
Target
OCA2
12
Indications
212
Trials
4
Developers

Approved by the FDA on Oct 26, 2001 (NDA021356). 3 approvals stand. FDA

Indications

12
  • Chronic hepatitis B

    Approved, FDA

  • Hepatitis b virus

    Approved, FDA

  • HIV-1 infection

    Approved, FDA

9 more

In the full profile

  • Target and mechanism2
  • Owner and partners4
  • Trials212
  • Evidence for its targets3
  • Competitors12
  • Signals15

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets